ELV
Elevance Health Inc.
$394.43
-4.68
(-1.17%)
Mkt Cap
85.54B
Volume
561,304
52W Range
274.84-436.24
Sector
Healthcare
Beta
0.69
EPS (TTM)
22.50 USD
P/E Ratio
17.53
Revenue (TTM)
201.11B USD
Rev Growth (5Y)
+10.3%
EPS Growth (5Y)
+6.7%
AlphaVal · Fair Value
What we estimate one share is worth
$314.00
Overvalued
moderate signal
25.6% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
68.7 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.
Company Description
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 199.12B | 176.81B | 171.34B | 156.59B | 138.64B | 121.87B | 104.21B | 92.11B | 90.04B | 84.98B | 79.24B | 73.92B |
| Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.10B | 4.57B | 4.81B | 3.75B | 3.84B | 2.47B | 2.56B | 2.57B |
| EPS | 25.18 | 25.81 | 25.38 | 24.56 | 25.25 | 18.23 | 18.81 | 14.53 | 14.70 | 9.39 | 9.73 | 9.31 |
| Free Cash Flow | 3.17B | 4.55B | 6.76B | 7.25B | 7.28B | 9.67B | 4.98B | 2.62B | 3.39B | 2.62B | 3.51B | 2.74B |
| FCF / Share | 14.31 | 19.55 | 29.03 | 30.20 | 29.85 | 38.54 | 19.51 | 10.30 | 13.26 | 9.94 | 13.45 | 10.23 |
| Operating CF | 4.29B | 5.81B | 8.06B | 8.40B | 8.36B | 10.69B | 6.06B | 3.83B | 4.18B | 3.20B | 4.12B | 3.37B |
| Total Assets | 121.49B | 116.89B | 108.93B | 102.75B | 97.46B | 88.28B | 78.25B | 72.47B | 71.46B | 66.39B | 63.06B | 62.93B |
| Total Debt | 33.23B | 32.70B | 26.65B | 25.80B | 24.89B | 21.84B | 21.21B | 19.21B | 19.93B | 15.73B | 15.86B | 15.04B |
| Cash & Equiv | 9.49B | 8.29B | 6.53B | 7.39B | 4.88B | 5.74B | 4.94B | 3.93B | 3.61B | 4.08B | 2.11B | 2.15B |
| Book Value | 43.88B | 41.31B | 39.31B | 36.24B | 36.06B | 33.20B | 31.73B | 28.54B | 26.50B | 25.10B | 23.04B | 24.25B |
| Return on Equity | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.14 | 0.15 | 0.13 | 0.14 | 0.10 | 0.11 | 0.11 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50.47B | 50.18B | 49.75B | 50.71B | 49.78B | 48.89B | 45.44B | 45.15B | 43.65B | 42.58B | 42.65B | 42.85B |
| Net Income | 1.46B | 1.76B | 547.00M | 1.19B | 1.74B | 2.18B | 418.00M | 1.02B | 2.30B | 2.25B | 856.00M | 1.29B |
| EPS | 6.71 | 8.00 | 2.47 | 5.32 | 7.72 | 9.64 | 1.84 | 4.36 | 9.91 | 9.65 | 3.67 | 5.48 |
| Free Cash Flow | 1.63B | 4.10B | (209.00M) | 775.00M | 1.79B | 821.00M | 384.00M | 2.35B | 124.00M | 1.70B | (3.30B) | 2.29B |
| FCF / Share | 7.46 | 18.59 | -0.94 | 3.43 | 7.91 | 3.63 | 1.69 | 10.06 | 0.53 | 7.30 | -14.15 | 9.75 |
| Operating CF | 1.91B | 4.33B | 84.00M | 1.14B | 2.05B | 1.02B | 706.00M | 2.68B | 447.00M | 1.98B | (2.97B) | 2.61B |
| Total Assets | 126.44B | 125.83B | 121.49B | 122.75B | 121.94B | 119.72B | 116.89B | 116.53B | 112.99B | 111.89B | 108.93B | 110.48B |
| Total Debt | 31.04B | 31.84B | 33.23B | 32.10B | 30.19B | 30.00B | 32.70B | 27.15B | 27.69B | 26.45B | 26.65B | 26.41B |
| Cash & Equiv | 10.23B | 9.66B | 9.49B | 8.71B | 8.56B | 7.50B | 8.29B | 7.87B | 6.50B | 6.23B | 6.53B | 10.92B |
| Book Value | 44.88B | 43.90B | 43.88B | 43.95B | 43.72B | 42.50B | 41.31B | 43.77B | 42.19B | 40.61B | 39.31B | 38.42B |
| Return on Equity | 0.03 | 0.04 | 0.01 | 0.03 | 0.04 | 0.05 | 0.01 | 0.02 | 0.05 | 0.06 | 0.02 | 0.03 |
ELV News
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
Is ELV Undervalued? DCF Says Worth $614
Barrow Hanley Mewhinney & Strauss LLC Takes $175.05 Million Position in Elevance Health, Inc. $ELV
31,408 Shares in Elevance Health, Inc. $ELV Acquired by B. Metzler seel. Sohn & Co. AG
Asahi Life Asset Management CO. LTD. Buys Shares of 1,279 Elevance Health, Inc. $ELV
Barden Capital Management Inc. Purchases New Stake in Elevance Health, Inc. $ELV
1,633 Shares in Elevance Health, Inc. $ELV Acquired by Avise Financial Cooperative Inc.
Elevance Health (ELV) Up 6.8% Since Last Earnings Report: Can It Continue?
Ballast Inc. Makes New Investment in Elevance Health, Inc. $ELV
Axiom Investment Management LLC Takes $542,000 Position in Elevance Health, Inc. $ELV